Jalaluddin, Elenamae .
HRN: 26-88-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2025
MUPIROCIN 2%, 15G (TUBE)
03/30/2025
04/06/2025
TOPICAL
2%
BID
SP RLTCS WITH IUD INSERTION
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes